Oxyphenisatin : Mass peristalsis in the human colon after contact with oxyphenisatin
In 2020 CRM Therapeutics, a Dutch drug-development company, initiated research for re-developing Vadimezan in combination with its proprietary targeted delivery platform.
Oxyphenisatin : Mass peristalsis in the human colon after contact with oxyphenisatin